SummaryRadioactive iodine (RAI) treatment is an effective treatment for differentiated thyroid cancer (DTC); however, many patients are refractory. Using targeted drugs to reinduce RAI sensitivity (“redifferentiation therapy”) has long been sought after as the holy grail in endocrine oncology.See related article by Weber et al., p. 4194

中文翻译：

---

再分化疗法——在后激酶抑制剂世界中回归根源

摘要放射性碘（RAI）治疗是分化型甲状腺癌（DTC）的有效治疗方法；然而，许多患者是难治性的。使用靶向药物来重新诱导 RAI 敏感性（“再分化疗法”）长期以来一直被视为内分泌肿瘤学的圣杯。参见 Weber 等人的相关文章，第 17 页。4194